Literature DB >> 17156289

Case-cohort designs and analysis for clustered failure time data.

Shou-En Lu1, Joanna H Shih.   

Abstract

Case-cohort design is an efficient and economical design to study risk factors for infrequent disease in a large cohort. It involves the collection of covariate data from all failures ascertained throughout the entire cohort, and from the members of a random subcohort selected at the onset of follow-up. In the literature, the case-cohort design has been extensively studied, but was exclusively considered for univariate failure time data. In this article, we propose case-cohort designs adapted to multivariate failure time data. An estimation procedure with the independence working model approach is used to estimate the regression parameters in the marginal proportional hazards model, where the correlation structure between individuals within a cluster is left unspecified. Statistical properties of the proposed estimators are developed. The performance of the proposed estimators and comparisons of statistical efficiencies are investigated with simulation studies. A data example from the Translating Research into Action for Diabetes (TRIAD) study is used to illustrate the proposed methodology.

Entities:  

Mesh:

Year:  2006        PMID: 17156289     DOI: 10.1111/j.1541-0420.2006.00584.x

Source DB:  PubMed          Journal:  Biometrics        ISSN: 0006-341X            Impact factor:   2.571


  11 in total

1.  Case-cohort analysis of clusters of recurrent events.

Authors:  Feng Chen; Kani Chen
Journal:  Lifetime Data Anal       Date:  2013-07-06       Impact factor: 1.588

2.  Marginal hazards model for case-cohort studies with multiple disease outcomes.

Authors:  S Kang; J Cai
Journal:  Biometrika       Date:  2009-12       Impact factor: 2.445

3.  Efficient Estimation of Semiparametric Transformation Models for Two-Phase Cohort Studies.

Authors:  Donglin Zeng; D Y Lin
Journal:  J Am Stat Assoc       Date:  2014-01-01       Impact factor: 5.033

4.  Marginal hazards regression for retrospective studies within cohort with possibly correlated failure time data.

Authors:  Sangwook Kang; Jianwen Cai
Journal:  Biometrics       Date:  2008-05-19       Impact factor: 2.571

Review 5.  Recent progresses in outcome-dependent sampling with failure time data.

Authors:  Jieli Ding; Tsui-Shan Lu; Jianwen Cai; Haibo Zhou
Journal:  Lifetime Data Anal       Date:  2016-01-13       Impact factor: 1.588

6.  Multiplicative rates model for recurrent events in case-cohort studies.

Authors:  Poulami Maitra; Leila D A F Amorim; Jianwen Cai
Journal:  Lifetime Data Anal       Date:  2019-02-08       Impact factor: 1.588

7.  Proportional hazards regression for the analysis of clustered survival data from case-cohort studies.

Authors:  Hui Zhang; Douglas E Schaubel; John D Kalbfleisch
Journal:  Biometrics       Date:  2011-03       Impact factor: 2.571

8.  Estimating effect of environmental contaminants on women's subfecundity for the MoBa study data with an outcome-dependent sampling scheme.

Authors:  Jieli Ding; Haibo Zhou; Yanyan Liu; Jianwen Cai; Matthew P Longnecker
Journal:  Biostatistics       Date:  2014-05-07       Impact factor: 5.899

9.  Association of Autism Spectrum Disorder With Prenatal Exposure to Medication Affecting Neurotransmitter Systems.

Authors:  Magdalena Janecka; Arad Kodesh; Stephen Z Levine; Shari I Lusskin; Alexander Viktorin; Rayees Rahman; Joseph D Buxbaum; Avner Schlessinger; Sven Sandin; Abraham Reichenberg
Journal:  JAMA Psychiatry       Date:  2018-12-01       Impact factor: 21.596

10.  Serial Fibroblast Growth Factor 23 Measurements and Risk of Requirement for Kidney Replacement Therapy: The CRIC (Chronic Renal Insufficiency Cohort) Study.

Authors:  Rupal Mehta; Xuan Cai; Jungwha Lee; Dawei Xie; Xue Wang; Julia Scialla; Amanda H Anderson; Jon Taliercio; Mirela Dobre; Jing Chen; Michael Fischer; Mary Leonard; James Lash; Chi-Yuan Hsu; Ian H de Boer; Harold I Feldman; Myles Wolf; Tamara Isakova
Journal:  Am J Kidney Dis       Date:  2019-12-19       Impact factor: 8.860

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.